RTRX insider filings

Travere Therapeutics, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-11-25. Screen RTRX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for RTRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Travere Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2020-11-254Clague Laura — Chief Financial OfficerGrant/award (A): 7,500 @ $0 · Sale (S): 3,750 @ $23.86 · Sale (S): 3,750 @ $22.72EDGAR
2020-11-174ROTE WILLIAM E. — Senior Vice President, R&DSale (S): 2,500 @ $23.96EDGAR
2020-11-174Clague Laura — Chief Financial OfficerSale (S): 7,500 @ $23.98EDGAR
2020-11-174REED ELIZABETH E — SVP, GC & Corporate SecretarySale (S): 2,500 @ $23.98EDGAR
2020-11-134ROTE WILLIAM E. — Senior Vice President, R&DGrant/award (A): 5,000 @ $0 · Sale (S): 2,500 @ $23.62EDGAR
2020-11-134Clague Laura — Chief Financial OfficerGrant/award (A): 15,000 @ $0 · Sale (S): 7,500 @ $23.61EDGAR
2020-11-134REED ELIZABETH E — SVP, GC & Corporate SecretaryGrant/award (A): 5,000 @ $0 · Sale (S): 2,500 @ $23.62EDGAR
2020-11-064ASELAGE STEVE — DirectorSale (S): 2,500 @ $21.26 · Sale (S): 20,625 @ $23EDGAR
2020-10-054Heerma Peter — Chief Commercial OfficerSale (S): 2,188 @ $18.90 · Sale (S): 2,188 @ $19.35EDGAR
2020-09-234ROTE WILLIAM E. — Senior Vice President, R&DSale (S): 1,500 @ $18.48EDGAR
2020-09-234Rosenberg Noah L. — Chief Medical OfficerSale (S): 750 @ $18.48EDGAR
2020-09-234Clague Laura — Chief Financial OfficerSale (S): 1,500 @ $18.48EDGAR
2020-09-234REED ELIZABETH E — SVP, GC & Corporate SecretarySale (S): 1,500 @ $18.48EDGAR
2020-09-224ROTE WILLIAM E. — Senior Vice President, R&DGrant/award (A): 3,000 @ $0 · Sale (S): 1,500 @ $18.59EDGAR
2020-09-224Rosenberg Noah L. — Chief Medical OfficerGrant/award (A): 3,000 @ $0 · Sale (S): 750 @ $18.59EDGAR
2020-09-224Dube Eric M — Chief Executive Officer, DirectorGrant/award (A): 25,000 @ $0 · Grant/award (A): 3,000 @ $0 · Sale (S): 9,240 @ $19.28 · Sale (S): 1,565 @ $19.29EDGAR
2020-09-224Clague Laura — Chief Financial OfficerGrant/award (A): 3,000 @ $0 · Sale (S): 1,500 @ $18.59EDGAR
2020-09-224REED ELIZABETH E — SVP, GC & Corporate SecretaryGrant/award (A): 3,000 @ $0 · Sale (S): 1,500 @ $18.59EDGAR
2020-08-064ASELAGE STEVE — DirectorSale (S): 2,500 @ $19.68EDGAR

Recent 8-K events — Travere Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-028-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-118-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-148-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RTRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs